ArticleHealthcare informatics research2025
Improving Online Drug Information: Insights from Quality Evaluation and Pharmaceutical System Design.
Article in Healthcare informatics research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectivesThe integration of digital technology has greatly expanded public access to health and drug-related information through the Internet. However, the rapid proliferation of unverified content on websites targeting the general population raises serious concerns about health misinformation. This study aimed to evaluate the quality of Indonesian drug information websites accessible to the public and to design a verified, web-based drug information system.
methodsA cross-sectional evaluation was conducted using the Quality Evaluation Scoring Tool (QUEST) to assess the quality of publicly available drug information websites in Indonesia. Development of the verified drug information platform followed the Rapid Application Development model, employing a prototyping approach.
resultsAmong the 14 publicly accessible drug information websites evaluated, 5 (35.71%) were classified as low quality (QUEST score ≤9), 4 (21.42%) as moderate quality (score 10-18), and 5 (35.71%) as high quality (score >18). The drug information website developed by the Faculty of Pharmacy, Universitas Andalas, achieved a high-quality rating, with a QUEST score of 27 (96.43%), although it received the lowest subscore in the Complementarity domain. Higher QUEST scores indicate better information quality.
conclusionsThe findings show that nearly half of the websites providing drug information to the Indonesian public are of low quality. The website developed by the Faculty of Pharmacy, Universitas Andalas, demonstrated strong overall quality, but improvements in the Complementarity domain are recommended to further strengthen user engagement and support.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.